Bigfoot Biomedical, known best for its grassroots approach to building an artificial pancreas for Type 1 diabetes, is emerging from hacker mode and raising some capital. The startup just brought in a ...
The Artificial Pancreas Devices Systems Market Report, published by Allied Market Research, suggests that the global market was valued at $0.4 billion in 2023 and is projected to reach $0.8 billion by ...
Four studies backed by the National Institutes of Health have either launched or are poised to launch in the near future. Researchers hope these studies will serve as the potential bridge between ...
Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod ® Insulin Management System (OmniPod System), today announced a license agreement and partnership ...
Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review ...
Researchers will soon undertake one of the largest-ever long-term clinical trials of a system designed to help regulate blood sugar levels of individuals with type 1 diabetes mellitus. If the ...
The device, if perfected, could help millions of diabetics, a researcher says. TRENTON, N.J. — An experimental artificial pancreas will soon be tested in diabetes patients, potentially sparing them ...
FRESNO, Calif. (KFSN) -- Justin Wood loves all things mechanical. Especially cars. This time of year, Justin's under the hood doing winter maintenance. Maintenance is a word he's lived with since age ...
SAN FRANCISCO, Calif. (KFSN) -- It could be life-changing technology for type 1 diabetics, a condition where the pancreas makes little insulin, or none at all. Doctors are hailing the so-called ...
When used in an appropriately trained and equipped clinic setting, supported open-source artificial pancreas systems (SOSAPS) are at least as safe and effective as retail APS, but with lower cost. An ...
Researchers working on an artificial pancreas believe they are just a few years away from a nearly carefree way for people with diabetes to monitor blood and inject insulin as needed. They believe ...